Interleukin-36 Receptor Antagonists [MoA] - N0000194040

Pharmacologic Code	N0000194040
Pharmacologic Name	Interleukin-36 Receptor Antagonists
Pharmacologic Uses	interleukin-36 receptor antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Interleukin-36 Receptor Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0597-0035	Spevigo	Non-Proprietary Name: Spesolimab-sbzo	Injection	Intravenous	Boehringer Ingelheim Pharmaceuticals, Inc.	ACTIVE
	0597-0620	Spevigo	Non-Proprietary Name: Spesolimab-sbzo	Injection	Intravenous	Boehringer Ingelheim Pharmaceuticals, Inc.	ACTIVE